|1.||Kaira, Kyoichi: 12 articles (05/2015 - 08/2010)|
|2.||Nakajima, Takashi: 12 articles (02/2014 - 01/2008)|
|3.||Yamamoto, Nobuyuki: 11 articles (02/2014 - 08/2010)|
|4.||Takahashi, Toshiaki: 11 articles (02/2014 - 08/2010)|
|5.||Endo, Masahiro: 11 articles (02/2014 - 08/2010)|
|6.||Ohde, Yasuhisa: 10 articles (02/2014 - 08/2010)|
|7.||Kondo, Haruhiko: 10 articles (09/2012 - 08/2010)|
|8.||Oriuchi, Noboru: 9 articles (02/2014 - 07/2003)|
|9.||Okumura, Takehiro: 9 articles (09/2012 - 08/2010)|
|10.||Murakami, Haruyasu: 9 articles (09/2012 - 08/2010)|
04/01/1995 - "Together, these data demonstrate that GLUT4 upregulation overcomes the glucose transporter translocation defect and alleviates insulin resistance in genetically diabetic mice, thus resulting in markedly improved glycemic control."
12/01/2015 - "Mitochondria dysfunction and decreased expression of glucose transporter (GLUT4) were identified as main factors of insulin resistance. "
10/15/2011 - "Repression of the glucose transporter 4 (GLUT4) gene as well as impaired GLUT4 translocation may be a mediator for fatty acid-induced insulin resistance. "
11/01/2009 - "Taken together, ANT from black soybean seed coat have anti-diabetic effects that are due, in part, to the regulation of glucose transporter 4 and prevention of insulin resistance and pancreatic apoptosis, suggesting a possible use as a drug to regulate diabetes."
06/01/2008 - "Glucose transporter isoform-3-null heterozygous mutation causes sexually dimorphic adiposity with insulin resistance."
06/01/2012 - "In this study, we examined the spatial distribution of the glycolysis and hypoxia related markers glucose transporter 1 (GLUT1) and monocarboxylate transporter 4 (MCT4) expression in relation to the vasculature in stage I, II and resectable stage IIIA NSCLC. "
04/01/2012 - "In this study, a significant association between over-expression of glucose transporter 1, a marker for hypoxia, and down-regulation of hMSH3 in CRC tissues was observed. "
12/01/2015 - "The expression of hypoxia-inducible factor 1α and glucose transporter 1 was evaluated on immunostained tumour sections using six-point grading scales. "
12/01/2015 - "A novel functional glucose transporter in the white shrimp Litopenaeus vannamei -LvGLUT2- is up-regulated during hypoxia in hepatopancreas."
12/01/2014 - "The glucose transporter 1 -GLUT1- from the white shrimp Litopenaeus vannamei is up-regulated during hypoxia."
|3.||Alzheimer Disease (Alzheimer's Disease)
01/01/1991 - "We found a marked decrease of about 50% in the density of the glucose transporter, but increased densities of beta 2- and alpha 2-adrenergic receptors in cerebral microvessels obtained from subjects with Alzheimer's disease. "
01/01/2014 - "Expression of the glucose transporter GLUT12 in Alzheimer's disease patients."
01/01/1995 - "Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone."
11/01/1994 - "Reduced glucose transporter concentrations in brains of patients with Alzheimer's disease."
01/01/1994 - "Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease."
01/01/2015 - "Recent studies proposed GLUT12 to be a major glucose transporter involved in the glycolytic metabolism of cancer cells. "
07/01/2014 - "The purpose of this study was to evaluate the expression of glucose transporter protein 1 (GLUT1) and p63 in patients with serous ovarian tumor (benign, borderline and malignant) and study their close relationship with the malignant transformation of serous ovarian tumors. "
05/17/2012 - "Few studies have focused on elucidating the molecular underpinnings of glucose transporter (GLUT) activation in cancer, knowledge that could facilitate identification of promising therapeutic targets. "
01/01/2011 - "Studies have implicated glucose transporter 1 expression as a prognostic and diagnostic marker in tumors, primarily in conjunction with positron emission tomography scan data. "
05/20/2010 - "Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays."
10/01/2002 - "The aim of this study is to determine the expression of the facilitative glucose transporter protein GLUT1 in human breast carcinomas and a possible correlation between GLUT1 expression and clinical outcome including disease-free or overall survival. "
01/01/2008 - "The aim of this study was to determine the biological significance of glucose transporter (Glut)-1 and Glut-3 expression in head and neck carcinoma (HNC). "
10/01/2000 - "In this study we evaluated the expression of the GLUT-1 glucose transporter in borderline and malignant epithelial neoplasms of the ovary. "
04/01/1995 - "In this study, we have characterized the Na/glucose transporter in polarized monolayers formed by the clonal human colon carcinoma cell line HT-29-D4. "
01/01/2014 - "The correlations between NDRG2 expression and glucose transporter 1 (GLUT1) expression in clinical breast carcinoma tissues were analysed. "
|6.||Complementary DNA (cDNA)
|9.||ferric oxide (iron oxide)
|10.||Insulin Receptor Substrate Proteins
|2.||Heterologous Transplantation (Xenotransplantation)
|3.||Drug Therapy (Chemotherapy)